Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 3-Oil drops amid rising stockpiles and COVID-19 demand concerns

Tue, 16th Mar 2021 05:48

(Changes dateline to London, updates prices, adds analyst
comment)

By Shadia Nasralla

LONDON, March 16 (Reuters) - Oil prices dropped on Tuesday,
extending declines to three consecutive days, as rising
stockpiles in the United States added to the risks to a demand
recovery after countries including Germany and France halted
COVID-19 vaccinations.

Brent crude was $1.03 cents, or 1.5%, lower at
$67.85 by 1002 GMT. U.S. crude was down 96 cents, or
1.4%, at $64.43 a barrel.

Germany, France and Italy plan to suspend AstraZeneca
COVID-19 injections after reports of possible serious
side effects, although the World Health Organization said there
was no established link to the vaccine.

These moves are deepening concerns about a slow pace of
vaccinations in the European Union, which may delay any economic
recovery from the pandemic in one of the hardest-hit areas.

The pandemic eviscerated demand for oil but prices have
recovered to levels seen before the global health crisis, only
to be capped as vaccination rollouts have been slow in most
countries.

In the United States, stockpiles are also rising because of
last month's "big freeze" which halted refining operations that
have taken time to fully return.

"Short-term direction will be set by the weekly U.S.
inventory reports," PVM analysts said in a note, adding the
strength of the dollar against other currencies is weighing on
oil prices.

The American Petroleum Institute, an industry group, will
report crude stock pile levels later on Tuesday, followed by
official numbers from the Department of Energy on Wednesday,
with analysts expecting another week of gains.

Crude inventories increased by 12.8 million barrels in the
week to March 5, against analysts' expectations for a rise of
less than 1 million barrels.

(Additional reporting by Aaron Sheldrick
Editing by Susan Fenton)

Related Shares

More News
3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by abo...

30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.